⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Evaluation of Votrient in Angiosarcoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Evaluation of Votrient in Angiosarcoma

Official Title: Single-arm, Multicenter, Open Label Phase II Trial to Evaluate the Efficacy of Pazopanib in Combination With Paclitaxel in Advanced and Relapsed Angiosarcoma

Study ID: NCT02212015

Conditions

Angiosarcoma

Study Description

Brief Summary: Open-label phase II trial investigating the efficacy and safety of the investigational combination of pazopanib and paclitaxel.

Detailed Description: Open-label phase II trial investigating the efficacy and safety of the investigational combination of pazopanib and paclitaxel.This multi-center, open-label, prospective, single arm phase II study was designed to evaluate the clinical efficacy and safety of the experimental combination of pazopanib with paclitaxel in the treatment of patients with advanced or metastatic angiosarcoma.The safety evaluations (physical examination, laboratory checks as defined in protocol, toxicity/adverse event assessment according Eastern Cooperative Oncology Group version 4.0) are scheduled every cycle at day 1, 8, 15 and 29 (= day 1 of the next cycle).

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Universitätsklinik Graz, Graz, , Austria

Universitätsklinik Wien, Wien, , Austria

Helios-Klinikum Bad Saarow, Bad Saarow, , Germany

Helios Klinikum Berlin-Buch, Berlin, , Germany

Universitätsklinikum Carl Gustav Carus, Dresden, , Germany

Universitätsklinikum Essen, Essen, , Germany

Universitätsklinikum Hamburg-Eppendorf, Hamburg, , Germany

Medizinische Hochschule Hannover, Hannover, , Germany

University Medical Center, Mannheim, , Germany

Klinikum der Universität München Campus Großhadern, München, , Germany

Contact Details

Name: Peter Hohenberger, MD

Affiliation: Universitätsmedizin Mannheim / Heidelberg University

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: